Wellell Inc. (TPE:4106)
24.40
+0.60 (2.52%)
May 29, 2026, 1:30 PM CST
Wellell Revenue
Wellell had revenue of 583.21M TWD in the quarter ending March 31, 2026, with 4.84% growth. This brings the company's revenue in the last twelve months to 2.43B, up 5.88% year-over-year. In the year 2025, Wellell had annual revenue of 2.40B with 0.74% growth.
Revenue (ttm)
2.43B
Revenue Growth
+5.88%
P/S Ratio
1.01
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.40B | 17.68M | 0.74% |
| Dec 31, 2024 | 2.39B | -260.47M | -9.84% |
| Dec 31, 2023 | 2.65B | -16.60M | -0.62% |
| Dec 31, 2022 | 2.66B | 289.67M | 12.20% |
| Dec 31, 2021 | 2.37B | 370.03M | 18.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| OK Biotech | 1.53B |
| Dynamic Medical Technologies | 1.38B |
| WeLeader Biomedical | 1.14B |
| Bioptik Technology Incorporation | 865.76M |
| A Plus Biotechnology | 858.89M |
| Medimaging Integrated Solution | 675.15M |
| Applied BioCode | 572.33M |
| Diamond Biotechnology | 501.49M |